sciagen.ai

Every pharma company wants to adopt AI. Very few have a plan for governing it. We built the AI Governance Workbench to close that gap a unified AI platform purpose-built for regulated life sciences. Swipe to see what → Explore → sciagen.ai/ai-workbench #LifeSciences #AI #PharmaQuality #GxP #Sciagen #WeAreSciagen #PharmaAI #AgenticAI

The largest live AI-in-Quality survey in Indian Pharma just happened. At the 6th Annual Pharma GMP & Quality Management 2026, 250+ Quality and Compliance professionals from 50+ Pharma and CDMO companies participated. Sciagen.ai ran a live, anonymous survey on AI adoption in GxP environments. This is the most representative real-time snapshot of where Indian Pharma stands on AI in Quality today. Here's what they told us: 📊 83% have used AI for quality, regulatory, or manufacturing tasks in the past year. The "should we?" debate is over. 📊 86% are stuck before scale. 49% experimenting | 37% in pilots | 9% scaled | 5% fully integrated. Fewer than 1 in 20 have truly integrated AI into the quality system. 📊 Top fears? Not budget. Reliability (50%) | Security (49%) | Compliance (45%) | Cost (21%) Hallucinations, data leaks, and broken audit trails aren't edge cases in GxP. They are the case. 📊 Where leaders want AI most: Deviations & CAPA | Content & Documents | Training & Competency | Audit Readiness The honest read: Indian Pharma is past curiosity and into commitment. But Reliability, Security, and Compliance are blocking the leap from pilot to production. This is exactly the gap Sciagen.ai was founded to close. ✅ Reliability - Outputs grounded in your SOPs, human-in-the-loop validated. No hallucinations. ✅ Security - Private cloud and on-prem. Your data never leaves your perimeter. ✅ Compliance - GxP-by-design. 21 CFR Part 11, GAMP 5, ALCOA+ from day one. 🔗 One Unified Pharma Life Science Platform & Workbench 🔗 20+ Production-grade Quality agents ready for deployment 🔗 Designed to work with your data and systems without replacing them To every Quality leader who answered honestly: thank you. You've given the industry its clearest AI snapshot yet. → https://lnkd.in/g2b-wxpm → https://www.sciagen.ai/ Meet our leaders to explore Sciagen.ai solutions: Pradeep Nagisetty | Adhisivan R. | Ramakrishna Rao R V #SciagenAI #PharmaQuality #AIinPharma #GxP #IndianPharma #CAPA #DigitalTransformation #GAMP5 #EBMGMP2026 #eminencebusinessmedia

Sciagen.ai officially launched at the 6th Annual Pharma GMP & Quality Management 2026 Thank you Eminence Business Media - A Eminence Group Company for the platform and the incredible energy at the event.

We’re excited to be part of the 6th Annual Pharma GMP & Quality Management 2026 as a Session Partner

Meet our experts at the 6th Annual Pharma GMP & Quality Management 2026 - April 23–24, Mumbai. Pradeep Nagisetty, Adhisivan R. and Ramakrishna Rao R V will be presenting our session: Unified AI Platform for Life Sciences. See you there. 📍 Westin Mumbai Garden City Eminence Business Media - A Eminence Group Company #Pharma #GMP #QualityManagement #LifeSciences #AI #EBMGMP2026 #eminencebusinessmedia #Sciagen #WeAreSciagen

Most Veeva programs go live successfully. But very few deliver full business value. Adoption plateaus. Integrations remain incomplete. Teams rely on workarounds. The challenge is not implementation. It is what happens after. That is where Sciagen works. → www.sciagen.ai #LifeSciences #Veeva #AI #Pharma #DigitalTransformation #Sciagen #AIProduction #FutureOfAI #AIConsulting

Low CRM adoption is rarely a training issue. Teams know how to use the system. They choose not to. Because the workflows do not match how they actually work, and the data does not support real decisions. That is why teams fall back on spreadsheets, notes, and side processes outside the CRM. Adoption improves when systems are designed around real work - not enforced through training. That is where Sciagen works. → www.sciagen.ai #LifeSciences #Veeva #AI #Pharma #DigitalTransformation #Sciagen #CRMAdoption

Audit findings are often treated as process failures. In reality, they are data problems. Fragmented systems, inconsistent records, and broken traceability create gaps that only surface under audit pressure. By then, teams are reacting - not fixing the root cause. The companies that stay audit-ready are the ones that built their data architecture right from the start. That is where Sciagen works. → www.sciagen.ai #LifeSciences #Veeva #AI #Pharma #DigitalTransformation #Sciagen #AIProduction #FutureOfAI #AIConsulting

Most AI initiatives in life sciences do not fail at the model level. They fail when moving from pilot to production. Data is fragmented. Systems are not integrated. Workflows are not aligned. That is where AI loses momentum - not in development, but in execution. The companies getting value from AI are the ones that fixed the foundation first. That is where Sciagen works. → https://www.sciagen.ai #LifeSciences #Veeva #AI #Pharma #DigitalTransformation #Sciagen #AIPilot #AIProduction #FutureOfAI #AIConsulting

Veeva and life sciences platforms have evolved significantly. But the real opportunity now is in how these systems work together in practice. Across organizations, teams are still navigating multiple workflows, reconciling data across systems, and bridging gaps between functions. Not because the technology doesn’t work. But because it wasn’t always designed for how work flows end-to-end across R&D, Quality, and Commercial. That’s where the next phase of transformation is happening. Sciagen is built for this shift. We work across Veeva, data, and AI to align systems, workflows, and teams into a single, connected operating model. #LifeSciences #Veeva #AI #Pharma #DigitalTransformation #Sciagen